Gender diverse children and young people

Key points:

  • Listen to the child, let the child lead their journey as much as possible.

  • Support parents to learn how to best support their child. Family support leads to better outcomes

  • If a child is insistent, consistent and persistent about their gender identity being different to that assigned at birth or clear distress expressed related to gender then social affirmation is usually beneficial.

  • Most families don’t require medical support for social transition/affirmation.

  • If puberty blockers (GnrH agonists) are being considered, referring to specialist services around age 9 years, prior to puberty onset is recommended. Some children are not distressed by puberty and don’t need blockers.

  • Puberty blockers can be used from tanner stage 2-3.

  • It is important to reassure the child and family that puberty does not move quickly.

  • For those assigned female at birth, the commencement of menses means much of physical puberty has usually occurred and the benefits of using a blocker often don’t outweigh the risks, given there are good alternatives for menses cessation.

  • For those assigned male at birth, puberty blockers are useful in later tanner stages for blocking ongoing effects of endogenous testosterone and can be started prior to gender affirming hormones.

  • Gender affirming hormone therapy is usually started from age 16 years (or younger in some cases) in those on puberty blockers who wish to go onto hormone therapy.

General Information

Puberty blockers

  • These are usually started as part of a multidisciplinary team process involving secondary care, and then continued in the primary care setting.

  • The timing of blocker initiation can impact future fertility and surgery options, which is why connecting with a health professional who can provide clear information to the family around this is recommended. In some areas, this may be a GP with a special interest in gender-affirming care or a GP liaising with secondary care.

  • It is important that access to secondary care does not delay timely access to puberty blockers for those children who will clearly benefit from them.

Gender affirming Hormone Therapy